DNA sequencer

Pandemic Opens Up Technology’s Future in Life Sciences

Retrieved on: 
星期二, 二月 28, 2023
Data Management, Technology, Health, General Health, Security, Research, Software, Networks, Internet, Mobile, Wireless, Science, Research report, Safety, Data management, Tech Mahindra, Wipro, Accenture, Thermo Fisher Scientific, HARMAN, Persistent Systems, TCS, Government Digital Service, PV, Orangi Pilot Project, Digital technology, Patient, ISG, Automation, LTIMindtree, Atos, PPD, Machine learning, Rising Star, HCLTech, DNA sequencer, COVID-19, Pharmaceutical industry, Pharmacovigilance, IQVIA

The 2022 ISG Provider Lens™ Life Sciences Digital Services global report finds that life sciences enterprises have made significant progress over the past three years in adopting digital technology at scale.

Key Points: 
  • The 2022 ISG Provider Lens™ Life Sciences Digital Services global report finds that life sciences enterprises have made significant progress over the past three years in adopting digital technology at scale.
  • The pandemic upended many common practices, including in-person patient visits and just-in-time supply deliveries, forcing companies to introduce new, digital processes.
  • “Technology is becoming part of the DNA of life sciences companies,” said Jennifer Stein, ISG partner and Life Sciences industry lead.
  • Life sciences companies are becoming increasingly centered on patients, treating them more often as the ultimate customers of the industry’s products, partly in response to rising patient activism, ISG says.

Element Introduces New Element LoopSeq™ Long-Read Sequencing Kits Designed for the AVITI™ System

Retrieved on: 
星期四, 十一月 10, 2022
SAN, RNA transfection, Genomics, Protein, WBE, Doctor of Philosophy, DNA sequencer, Research, Element, Virus, Science, Engineering, Sunday Faleye, CEO, Acquisition, Arizona State University, Bachelor of Engineering, COVID-19, Video game console, Vaccine, Enterovirus

SAN DIEGO, Nov. 10, 2022 /PRNewswire/ -- Element Biosciences, Inc.— developer of an innovative DNA sequencing platform disrupting the genomics industry — today announced the availability of its Element LoopSeq long-read sequencing technology kits for AVITI, giving the Element AVITI System the power of both short- and long-read sequencing on the same instrument. Element is the first company to own a general purpose long-read technology that runs on its native short-read sequencer.

Key Points: 
  • SAN DIEGO, Nov. 10, 2022 /PRNewswire/ -- Element Biosciences, Inc. developer of an innovative DNA sequencing platform disrupting the genomics industry today announced the availability of its Element LoopSeq long-read sequencing technology kits for AVITI, givingthe Element AVITI System the power of both short- and long-read sequencing on the same instrument.
  • Element LoopSeq is an extraordinarylong-read sequencing chemistry that provides synthetic long-read capabilities on AVITI.
  • For microbiome researchers, 16S LoopSeq for AVITI enables full-length 16S sequencing for up to 96 samples on the AVITI system.
  • Register here: https://www.elementbiosciences.com/events/webinar-beyond-covid
    For more information about Element LoopSeq, other LoopSeq kits and the AVITI System, including detailed specifications, application data, and performance testimonials, visit www.elementbiosciences.com
    Element Biosciences is a multi-disciplinary life science company developing disruptive DNA sequencing technology for research and diagnostic markets.

Pacific Biosciences Acquires Circulomics – A Leading High Molecular Weight DNA Extraction Company

Retrieved on: 
星期二, 八月 3, 2021
Branches of biology, Biology, Life sciences, DNA sequencing, Molecular biology, Biotechnology, Pacific Biosciences, DNA, Bioinformatics, Third-generation sequencing, Read, DNA sequencer

MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (Pacific Biosciences or PacBio), a leading provider of high-quality, long-read sequencing platforms, announced today that it acquired Circulomics Inc. (Circulomics), a Maryland-based biotechnology company focused on delivering highly differentiated sample prep products that enable genomic workflows.

Key Points: 
  • MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (Pacific Biosciences or PacBio), a leading provider of high-quality, long-read sequencing platforms, announced today that it acquired Circulomics Inc. (Circulomics), a Maryland-based biotechnology company focused on delivering highly differentiated sample prep products that enable genomic workflows.
  • Scientists recognize Circulomics as a leader in extracting high quality, high molecular weight (HMW) DNA from almost any sample type.
  • High quality, long-read sequencing begins with high quality, long DNA.
  • Circulomics Nanobind magnetic disks protect DNA from shearing to generate long reads across a broad range of sample types.

Global DNA Sequencing Technologies, Markets & Companies - Market Report to 2030

Retrieved on: 
星期一, 四月 26, 2021
Branches of biology, Biology, Molecular biology, Life sciences, DNA sequencing, Biotechnology, DNA, In science, DNA sequencer, Sequencing

b'DUBLIN, April 26, 2021 /PRNewswire/ -- The "DNA Sequencing - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com\'s offering.\nThis report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications.

Key Points: 
  • b'DUBLIN, April 26, 2021 /PRNewswire/ -- The "DNA Sequencing - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com\'s offering.\nThis report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications.
  • The value of DNA sequencer market in 2020 is described with estimates for 2024 and 2030.
  • Several marketing strategies have been outlined.\nThe report includes profiles of 149 companies involved in sequencing and their 173 collaborations.
  • The report text is supplemented by 42 tables, 25 figures, and 500 selected references to the literature.\nThe report includes information on the following:\n'

Next-generation Sequencing (NGS) Market worth $24.2 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
星期二, 四月 20, 2021
Branches of biology, Biology, Molecular biology, Life sciences, DNA sequencing, Biotechnology, DNA, In science, Massive parallel sequencing, NGS, Sequencing, DNA sequencer

However, the end-user budget constraints in developing countries is expected to hinder the overall growth rate.\nThe NGS Market by product & services is categorized into presequencing products & services, NGS platforms, NGS consumables, services for NGS platforms, sequencing services, and bioinformatics.

Key Points: 
  • However, the end-user budget constraints in developing countries is expected to hinder the overall growth rate.\nThe NGS Market by product & services is categorized into presequencing products & services, NGS platforms, NGS consumables, services for NGS platforms, sequencing services, and bioinformatics.
  • The large share of this segment can be attributed to growing number of sequencing procedures and launch of easy-to-use consumables.
  • Sequencing services are expected to register the highest CAGR during the forecast period due to expanding NGS services portfolio of companies and increasing adoption of advanced NGS platforms by service providers.\nBased on technology, the next-generation sequencing (NGS) market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing, and other sequencing technologies.
  • Sequencing by synthesis segment dominated the market in 2020 owing to an increase in availability of NGS platforms based on sequencing by synthesis technology.\nOn the basis of application, the next-generation sequencing (NGS) market is categorized into diagnostics, drug discovery, agricultural & animal research, and other applications.

Next-generation Sequencing (NGS) Market worth $24.2 billion by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
星期二, 四月 20, 2021
Branches of biology, Biology, Molecular biology, Life sciences, DNA sequencing, Biotechnology, DNA, In science, Massive parallel sequencing, NGS, Sequencing, DNA sequencer

However, the end-user budget constraints in developing countries is expected to hinder the overall growth rate.\nThe NGS Market by product & services is categorized into presequencing products & services, NGS platforms, NGS consumables, services for NGS platforms, sequencing services, and bioinformatics.

Key Points: 
  • However, the end-user budget constraints in developing countries is expected to hinder the overall growth rate.\nThe NGS Market by product & services is categorized into presequencing products & services, NGS platforms, NGS consumables, services for NGS platforms, sequencing services, and bioinformatics.
  • The large share of this segment can be attributed to growing number of sequencing procedures and launch of easy-to-use consumables.
  • Sequencing services are expected to register the highest CAGR during the forecast period due to expanding NGS services portfolio of companies and increasing adoption of advanced NGS platforms by service providers.\nBased on technology, the next-generation sequencing (NGS) market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing, and other sequencing technologies.
  • Sequencing by synthesis segment dominated the market in 2020 owing to an increase in availability of NGS platforms based on sequencing by synthesis technology.\nOn the basis of application, the next-generation sequencing (NGS) market is categorized into diagnostics, drug discovery, agricultural & animal research, and other applications.

Global Next Generation Sequencing Market Report 2020-2030: Focus on Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing & Nanopore Sequencing

Retrieved on: 
星期五, 一月 15, 2021
Branches of biology, Biology, Molecular biology, Life sciences, Biotechnology, DNA sequencing, Ion semiconductor sequencing, Sequencing, Nanopore sequencing, DNA sequencer

Next Generation Sequencing Global Market Opportunities and Strategies 2020-30: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global next generation sequencing market.

Key Points: 
  • Next Generation Sequencing Global Market Opportunities and Strategies 2020-30: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global next generation sequencing market.
  • The next generation sequencing market consists of sales of devices and equipment used in next generation sequencing and related services by entities (organizations, sole traders and partnerships) that manufacture next generation sequencing equipment.
  • The next generation sequencing market is also segmented by technology into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing and others.
  • The ion semiconductor sequencing was the largest segment of the next generation sequencing market segmented by technology, accounting for 75.8% of the total market in 2019.

Global Next Generation Sequencing Market Opportunities and Strategies Report 2020-2030 Featuring Illumina, Thermo Fisher Scientific, Agilent Technologies, Pacific Biosciences of California & QIAGEN - ResearchAndMarkets.com

Retrieved on: 
星期四, 一月 14, 2021
Biotechnology, Health, Genetics, Technology, Software, Branches of biology, Biology, Molecular biology, Life sciences, Biotechnology, DNA, Ion semiconductor sequencing, Sequencing, Nanopore sequencing, DNA sequencing, DNA sequencer

The "Next Generation Sequencing Global Market Opportunities and Strategies 2020-30: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Next Generation Sequencing Global Market Opportunities and Strategies 2020-30: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's offering.
  • Next Generation Sequencing Global Market Opportunities and Strategies 2020-30: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global next generation sequencing market.
  • The next generation sequencing market is also segmented by technology into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing and others.
  • North America was the largest region in the global next generation sequencing market, accounting for 34.7% of the total in 2019.

The world's first DNA "tricorder" in your pocket

Retrieved on: 
星期一, 十二月 7, 2020
Branches of biology, Biology, Science and technology, Molecular biology, DNA sequencing, Biotechnology, DNA, Oxford Nanopore Technologies, Tricorder, DNA sequencer, Nanopore, IPhone

By pairing an iPhone with a handheld DNA sequencer, users can create a mobile genetics laboratory, reminiscent of the "tricorder" featured in Star Trek.

Key Points: 
  • By pairing an iPhone with a handheld DNA sequencer, users can create a mobile genetics laboratory, reminiscent of the "tricorder" featured in Star Trek.
  • The iPhone app was developed to complement the tiny DNA sequencing devices being made by Oxford Nanopore.
  • He and Schatz realized that:
    "As the sequencers continued to get smaller, there were no technologies available to let you study that DNA on a mobile device.
  • Most of the studying of DNA: aligning, analyzing, is done on large server clusters or high-end laptops."

Universal Sequencing Technology and Shanghai Bioscience Form a Partnership for the Distribution of TELL-Seq™ Linked-Read NGS Library Prep Products

Retrieved on: 
星期三, 十月 14, 2020
Branches of biology, Biology, Life sciences, Molecular biology, DNA sequencing, Biotechnology, DNA, In science, Sequencing, Massive parallel sequencing, DNA sequencer

Universal Sequencing Technology was founded by next generation DNA sequencing veterans from Roche/454.

Key Points: 
  • Universal Sequencing Technology was founded by next generation DNA sequencing veterans from Roche/454.
  • Shanghai Bioscience Ltd (Bioscience), established in 2005, was the first company in China focused on the sales of life science laboratory consumables.
  • Universal Sequencing Technology was established by a group of NGS technology veterans.
  • Currently, UST has filed a total of 25 provisional patent filings covering linked, long-read library preparation chemistry and groundbreaking 3rd generation DNA sequencing technology.